MGC Pharmaceuticals Ltd
ASX:MXC

Watchlist Manager
MGC Pharmaceuticals Ltd Logo
MGC Pharmaceuticals Ltd
ASX:MXC
Watchlist
Price: 0.415 AUD Market Closed
Market Cap: 18.2m AUD

Operating Margin
MGC Pharmaceuticals Ltd

-1 171%
Current
-557%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 171%
=
Operating Profit
-15.5m
/
Revenue
1.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
MGC Pharmaceuticals Ltd
ASX:MXC
18.2m AUD
-1 171%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
496.6B USD
27%
CH
Roche Holding AG
SIX:ROG
259.2B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
212B GBP
24%
CH
Novartis AG
SIX:NOVN
208.2B CHF
33%
US
Merck & Co Inc
NYSE:MRK
251.4B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
143.2B USD
29%
No Stocks Found

MGC Pharmaceuticals Ltd
Glance View

Market Cap
18.2m AUD
Industry
Pharmaceuticals

MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-21. The firm is primarily focused on producing standardized, phytocannabinoid and plant-derived medicines. The Company’s Nature to Medicine strategy comprises the entire supply chain, from botanical research, to develop new strains of Cannabis Sativa, preclinical and clinical research, product manufacturing, distribution, as well as the development of drug delivery systems. The Group has also completed a Phase II double-blind, randomized, placebo controlled clinical trial in Israel and India, to evaluate the safety and efficacy of a natural anti-inflammatory based formulation ArtemiC on patients diagnosed with Corona Virus Disease 2019 (COVID-19).

MXC Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 171%
=
Operating Profit
-15.5m
/
Revenue
1.3m
What is the Operating Margin of MGC Pharmaceuticals Ltd?

Based on MGC Pharmaceuticals Ltd's most recent financial statements, the company has Operating Margin of -1 171%.

Back to Top